PubMed=5922251; DOI=10.1038/bjc.1966.58; PMCID=PMC2007999
Epstein M.A., Barr Y.M., Achong B.G.
Preliminary observations on new lymphoblast strains (EB4, EB5) from Burkitt tumours in a British and a Ugandan patient.
Br. J. Cancer 20:475-479(1966)

PubMed=6074691; DOI=10.1038/bjc.1967.79; PMCID=PMC2008180
Bishun N.P., Sutton R.N.P.
Cytogenetic and other studies on the EB4 line of Burkitt tumour cells.
Br. J. Cancer 21:675-678(1967)

PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x
Povey S., Jeremiah S., Arthur E., Steel M., Klein G.
Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.
Ann. Hum. Genet. 44:119-133(1980)

PubMed=2998993
Steel C.M., Morten J.E.N., Foster E.
The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
IARC Sci. Publ. 60:265-292(1985)

PubMed=3923440; DOI=10.1093/nar/13.8.2931; PMCID=PMC341205
Anderson M.L.M., Brown L., McKenzie E., Kellow J.E., Young B.D.
Cloning and sequence analysis of an Ig lambda light chain mRNA expressed in the Burkitt's lymphoma cell line EB4.
Nucleic Acids Res. 13:2931-2941(1985)